Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Dr Simon Chandler joins Ora as a senior director

He brings 15 years of ophthalmic industry experience

- PMLiVE

Wearables – the technologist’s view

Patient insight is key to a successful solution

LEO expands innovation lab

Adds offices in France and Canada to new digital unit

- PMLiVE

Deal Watch February 2016

Abbott, AstraZeneca and Sanofi among those featured in this month’s roundup of pharma deal activity

- PMLiVE

Diabetes: Let’s cut the Gordian knot by Debashis Bhattacharya and Kamlesh Sheth

Digital health specialists Aegleio suggest that a culture change is needed to cope with the rise of diabetes in the UK.

Say Communications

- PMLiVE

J&J drops NGF blocker fulranumab

Says decision to return rights to Amgen based on “strategic portfolio prioritisation”

- PMLiVE

GSK gene therapy tops CHMP recommendations

ADA-SCID treatment Strimvelis set for European approval

Fighting falsified drugs

Is the introduction of the Falsified Medicines Directive enough?

- PMLiVE

ImmuneXcite boosts senior leadership

Eric Furfine, Ann DeWitt, Jim Geraghty and John Edwards join the firm

PixarBio promotes Glenn Reiser

He becomes vice president of external affairs

- PMLiVE

Better insights come from better evidence

With the current data overload, it is critical that marketers have data literacy

- PMLiVE

GSK unveils access plan for low-income countries

Will file patents for its drugs according to each country’s 'economic maturity'

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links